![Ian McNiece](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian McNiece
No open positions remaining
Profile
Ian K.
McNiece worked as Head-Developmental Hematology Laboratory at Amgen, Inc. from 1997 to 1998.
Served as Professor at the University of Colorado Health Sciences Center from 1997 to 2002, at The Johns Hopkins University from 2003 to 2007, at the University of Miami from 2007 to 2012, and at The University of Texas M.D.
Anderson Cancer Center from 2012 to 2016.
Held the position of Chief Scientific Officer & Director at Proteonomix, Inc. from 2011 to 2012.
Directed at The Foundation For The Accreditation of Cellular Therapy from 2010 to 2023.
Chief Scientific Officer at BioCardia, Inc. from 2017 to 2023.
Earned a doctorate from the University of Melbourne in 1986.
Former positions of Ian McNiece
| Companies | Position | End |
|---|---|---|
The Foundation For The Accreditation of Cellular Therapy
 The Foundation For The Accreditation of Cellular Therapy The Foundation For The Accreditation of Cellular Therapy is a non-profit company based in Omaha, NE. | Director/Board Member | 2023-05-28 |
| BIOCARDIA, INC. | Chief Tech/Sci/R&D Officer | 2023-05-28 |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services Provides cancer patient care, research and prevention for cancer | Corporate Officer/Principal | 2015-12-31 |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2011-12-31 |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2007-04-30 |
Training of Ian McNiece
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
90
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Colorado Health Sciences Center
 University of Colorado Health Sciences Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services Provides cancer patient care, research and prevention for cancer | Consumer Services |
Proteonomix, Inc.
 Proteonomix, Inc. Medical/Nursing ServicesHealth Services Develops potential stem cell therapies for the treatment of diabetes and cardiac injury | Health Services |
The Foundation For The Accreditation of Cellular Therapy
The Foundation For The Accreditation of Cellular Therapy The Foundation For The Accreditation of Cellular Therapy is a non-profit company based in Omaha, NE. | |
BioCardia, Inc.
 BioCardia, Inc. BiotechnologyHealth Technology Develops biotherapeutics for cardiovascular disease | Health Technology |
- Stock Market
- Insiders
- Ian McNiece
